DIANA CHEN: Open Payments
NPI 1518919091 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,146 in 133 payments from 28 companies in 2025. Trend: 2023 $2,773 · 2024 $3,310 · 2025 $3,146
Food & beverage: $3,146
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $579 |
| AstraZeneca Pharmaceuticals LP | 20 | $577 |
| ABBVIE INC. | 19 | $251 |
| Lilly USA, LLC | 11 | $243 |
| PFIZER INC. | 14 | $198 |
| ViiV Healthcare Company | 4 | $161 |
| Boston Scientific Corporation | 1 | $142 |
| Exact Sciences Corporation | 6 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $114 |
| Hologic Sales and Service, LLC | 1 | $104 |
Products named: Ozempic, BREZTRI, MOUNJARO, FARXIGA, APRETUDE, Wegovy, WATCHMAN FLX, VRAYLAR.
Industry payments across OK — which companies pay providers there.
